Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• NP17419.RAGug7slL4kCYFrD4svdiRIkT1SBD_R6t4mGILrXYtBDY130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17419.RAGug7slL4kCYFrD4svdiRIkT1SBD_R6t4mGILrXYtBDY130_provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP888767.RAdl5WO4XpCojiv2icJ5mJNFJGih04MvpPfNp0hAEZ2eM130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP888767.RAdl5WO4XpCojiv2icJ5mJNFJGih04MvpPfNp0hAEZ2eM130_provenance.
• NP16482.RAho4VilOiolAdvRgVL7_jiRDunflWBaKIa2DADsPV5EE130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP16482.RAho4VilOiolAdvRgVL7_jiRDunflWBaKIa2DADsPV5EE130_provenance.
• NP104857.RAiFFjVNCHePZSEzsZtvc3MRlpQqRVd92U6JD0qVbQA6Y130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP104857.RAiFFjVNCHePZSEzsZtvc3MRlpQqRVd92U6JD0qVbQA6Y130_provenance.
• NP105564.RAo5_xG-oclIBrlMgo-iBVtsY9FlG4hAXC5t3SJ72-Hig130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105564.RAo5_xG-oclIBrlMgo-iBVtsY9FlG4hAXC5t3SJ72-Hig130_provenance.
• NP100620.RAVB01yU97qynzrCAItIdSNeLFyLoYU9OO0vJ50113prg130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100620.RAVB01yU97qynzrCAItIdSNeLFyLoYU9OO0vJ50113prg130_provenance.
• NP100621.RAYzPwPLmKmjUgKVIwIfAlH-502qSscwjK1jVPkKe4RBY130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100621.RAYzPwPLmKmjUgKVIwIfAlH-502qSscwjK1jVPkKe4RBY130_provenance.
• NP100623.RAT2s1d3pO4fo2qZm8aS2U4uDfNnybvaQEFMD6VITmubI130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100623.RAT2s1d3pO4fo2qZm8aS2U4uDfNnybvaQEFMD6VITmubI130_provenance.
• assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP17495.RAVaFtSax9n2VVaZuLVm4NjQ8E7KlOt-ZkHL1Dm5bWYDk130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP17495.RAVaFtSax9n2VVaZuLVm4NjQ8E7KlOt-ZkHL1Dm5bWYDk130_provenance.
• NP549931.RAZe5ZxicZTQmYX-flp1bAUVWXqf9S5VpuJTnlGHDYwrQ130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP549931.RAZe5ZxicZTQmYX-flp1bAUVWXqf9S5VpuJTnlGHDYwrQ130_provenance.
• NP100624.RABCXkf8hN9WUjaBjG5rpj2OJYBuC6_a_N9jzyCmBrP-U130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100624.RABCXkf8hN9WUjaBjG5rpj2OJYBuC6_a_N9jzyCmBrP-U130_provenance.
• NP100619.RAnnbC6V2F9vtLfPgM5OI0HqQUac5sbrO81AED-O6TS6E130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100619.RAnnbC6V2F9vtLfPgM5OI0HqQUac5sbrO81AED-O6TS6E130_provenance.
• NP104669.RA6ru1wM1HHjP03GWLVpXX-E808GZMVtuwbDIOPcoCjgs130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP104669.RA6ru1wM1HHjP03GWLVpXX-E808GZMVtuwbDIOPcoCjgs130_provenance.
• NP105386.RAxOZ1nlZCqUkTF9seICVNNiUw7Onbtof-7exi2g9j58s130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP105386.RAxOZ1nlZCqUkTF9seICVNNiUw7Onbtof-7exi2g9j58s130_provenance.
• NP100622.RAx1rckhNXm9NWXmWnyjBP4mzyQoSJHohAne7wOIRwGv4130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100622.RAx1rckhNXm9NWXmWnyjBP4mzyQoSJHohAne7wOIRwGv4130_provenance.
• NP100625.RA8A2LJ_rXbOCxQvtjLyZLymrUOCupG02afmneqTYzbEE130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100625.RA8A2LJ_rXbOCxQvtjLyZLymrUOCupG02afmneqTYzbEE130_provenance.
• NP100626.RA4u5XM6TJmvBDr9Yl6i3y_U7sOEVJYto-KC6iqrEty5I130_assertion description "[Evaluation of glutathione S-transferase polymorphisms and mutagen sensitivity as risk factors for the development of second primary tumors in patients previously diagnosed with early-stage head and neck cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP100626.RA4u5XM6TJmvBDr9Yl6i3y_U7sOEVJYto-KC6iqrEty5I130_provenance.